Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Giovanni Baraldi

Showing results (121-130 of 159) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry|November 14, 2008
Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonistsPier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2005
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocyclesRomeo Romagnoli, Pier Giovanni Baraldi, M Katherine Jung, et al.
Journal of Medicinal Chemistry|August 12, 2009
2-Arylamino-4-amino-5-aroylthiazoles. "One-pot" synthesis and biological evaluation of a new class of inhibitors of tubulin polymerizationRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Journal of Medicinal Chemistry|May 24, 2013
Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Giulia Saponaro, et al.
Medicinal Research Reviews|July 7, 2017
A<sub>3</sub> Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to TherapyKenneth A Jacobson, Stefania Merighi, Katia Varani, et al.
Journal of Medicinal Chemistry|December 14, 2011
Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonistsPier Giovanni Baraldi, Stefania Baraldi, Giulia Saponaro, et al.
European Journal of Medicinal Chemistry|October 27, 2011
One-pot synthesis and biological evaluation of 2-pyrrolidinyl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazole: a unique, highly active antimicrotubule agentRomeo Romagnoli, Pier Giovanni Baraldi, Carlota Lopez Cara, et al.
Journal of Medicinal Chemistry|December 6, 2011
Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activityRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Journal of Medicinal Chemistry|June 26, 2007
From tyrosine to glycine: synthesis and biological activity of potent antagonists of the purinergic P2X7 receptorRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Journal of Medicinal Chemistry|August 30, 2008
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptorRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Pageof 16

Showing results (121-130 of 159) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry|November 14, 2008
Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonistsPier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2005
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocyclesRomeo Romagnoli, Pier Giovanni Baraldi, M Katherine Jung, et al.
Journal of Medicinal Chemistry|August 12, 2009
2-Arylamino-4-amino-5-aroylthiazoles. "One-pot" synthesis and biological evaluation of a new class of inhibitors of tubulin polymerizationRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Journal of Medicinal Chemistry|May 24, 2013
Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Giulia Saponaro, et al.
Medicinal Research Reviews|July 7, 2017
A<sub>3</sub> Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to TherapyKenneth A Jacobson, Stefania Merighi, Katia Varani, et al.
Journal of Medicinal Chemistry|December 14, 2011
Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonistsPier Giovanni Baraldi, Stefania Baraldi, Giulia Saponaro, et al.
European Journal of Medicinal Chemistry|October 27, 2011
One-pot synthesis and biological evaluation of 2-pyrrolidinyl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazole: a unique, highly active antimicrotubule agentRomeo Romagnoli, Pier Giovanni Baraldi, Carlota Lopez Cara, et al.
Journal of Medicinal Chemistry|December 6, 2011
Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activityRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Journal of Medicinal Chemistry|June 26, 2007
From tyrosine to glycine: synthesis and biological activity of potent antagonists of the purinergic P2X7 receptorRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Journal of Medicinal Chemistry|August 30, 2008
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptorRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Pageof 16